This is a routine CEO appointment with no material financial implications. Monitor for any strategic shifts under the new CEO, but no immediate trading catalyst is present.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 29 $31.81entry
- T+1 · 5mo ago −1.29%α −2.07% · $31.40
- T+5 · 4mo ago +7.29%α +5.91% · $34.13
- T+20 · 4mo ago +6.99%α +7.27% · $34.04
- T+60 · 8w ago +10.50%α +6.11% · $35.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Phibro Animal Health appointed Daniel (Dani) Bendheim as CEO and President effective July 1, 2026, with an employment agreement including a base salary of $850,000, target bonus of 50% of base, and a grant of 300,000 performance-based RSUs vesting based on stock price targets ($70–$100+ by June 30, 2031). This is a routine leadership transition with standard compensation terms and no financial data or red flags.
Key Facts
- Daniel Bendheim appointed CEO and President effective July 1, 2026
- Base salary of $850,000 per year with target bonus of 50% of base salary
- Initial grant of 300,000 performance-based RSUs vesting based on 90-day average stock price from $70 to $100+ by June 30, 2031
- Annual time-vesting RSU target value of approximately 50% of base salary
- Change-in-control provisions allow accelerated vesting under certain conditions
Financial Impact
No immediate financial impact; the 300,000 RSU grant is performance-based and long-dated, representing potential dilution of approximately 0.7% of current shares outstanding (based on market cap of $1.3B and stock price context).
Risk Factors
- None from this filing; the appointment appears planned and uncontroversial
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-078323 |
| Document: 0001104659-26-078323-index-headers.html | 0001104659-26-078323 |
| Document: 0001104659-26-078323-index.html | 0001104659-26-078323 |
| Document: 0001104659-26-078323.txt | 0001104659-26-078323 |
Track record
9 reports on PAHC
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +37.96% at T+20 after the Apr 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $35.40 to $35.46 Now $35.02 −1.07% ▲ +0.17% −3.12% vs SPY
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $39.43 to $35.15 Now $35.02 −11.18% ▼ −10.85% −9.94% vs SPY
- Oct 19, 202628d ago SC 13G/A Bearish 5/10 Entry $38.80 to $38.38 Now $35.02 +9.74% ▲ +1.08% +1.16% vs SPY
- Jul 28, 202615w ago 8-K Neutral 2/10 Entry $36.95 to $36.01 Now $35.02 −5.22% ▼ −2.54% −8.07% vs SPY
- Jun 26, 202620w ago 8-K Neutral 2/10 Viewing Entry $31.81 to $34.13 Now $35.02 +10.09% ▲ +7.29% +5.91% vs SPY
- May 6, 202627w ago 8-K Bullish 6/10 Entry $43.16 to $35.26 Now $35.02 −18.86% ▼ −18.30% −19.81% vs SPY
- May 5, 202627w ago 8-K Neutral 2/10 Entry $58.50 to $36.58 Now $35.02 −40.14% ▼ −37.47% −38.60% vs SPY
- Apr 30, 202628w ago 8-K Neutral 4/10 Entry $54.66 to $39.83 Now $35.02 −35.93% ▼ −27.13% −29.47% vs SPY
- Apr 27, 202629w ago 8-K Bearish 5/10 Entry $54.29 to $54.68 Now $35.02 +35.49% ▼ −0.72% +0.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers